Colorectal cancer screening: Clinical Practice Guidelines in oncology™

Bernard Levin; James S. Barthel; Randall W. Burt; Donald S. David; James M. Ford; Francis M. Giardiello; Stephen B. Gruber; Amy L. Halverson; Stanley Hamilton; Wendy Kohlmann; Kirk A. Ludwig; Patrick M. Lynch; Christopher Marino; Edward W. Martin; Robert J. Mayer; Boris Pasche; Samuel J. Pirruccello; Ashwani Rajput; M. Sambasiva Rao; Moshe Shike; Gideon Steinbach; Jonathan P. Terdiman; David Weinberg; Sidney J. Winawer

doi:10.6004/jnccn.2006.0033

Colorectal cancer screening: Clinical Practice Guidelines in oncology™

Bernard Levin, James S. Barthel, Randall W. Burt, Donald S. David, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley Hamilton, Wendy Kohlmann, Kirk A. Ludwig, Patrick M. Lynch, Christopher Marino, Edward W. Martin, Robert J. Mayer, Boris Pasche, Samuel J. Pirruccello, Ashwani Rajput, M. Sambasiva Rao, Moshe ShikeGideon Steinbach, Jonathan P. Terdiman, David Weinberg, Sidney J. Winawer

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Abstract

Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema.

Original language	English (US)
Pages (from-to)	384-420
Number of pages	37
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	4
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2006.0033
State	Published - Apr 2006
Externally published	Yes

Keywords

APC
Adenoma
Colorectal cancer
FAP
Fecal occult blood test
HNPCC
NCCN Clinical Practice Guidelines

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2006.0033

Cite this

Levin, B., Barthel, J. S., Burt, R. W., David, D. S., Ford, J. M., Giardiello, F. M., Gruber, S. B., Halverson, A. L., Hamilton, S., Kohlmann, W., Ludwig, K. A., Lynch, P. M., Marino, C., Martin, E. W., Mayer, R. J., Pasche, B., Pirruccello, S. J., Rajput, A., Rao, M. S., ... Winawer, S. J. (2006). Colorectal cancer screening: Clinical Practice Guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(4), 384-420. https://doi.org/10.6004/jnccn.2006.0033

Levin, B, Barthel, JS, Burt, RW, David, DS, Ford, JM, Giardiello, FM, Gruber, SB, Halverson, AL, Hamilton, S, Kohlmann, W, Ludwig, KA, Lynch, PM, Marino, C, Martin, EW, Mayer, RJ, Pasche, B, Pirruccello, SJ, Rajput, A, Rao, MS, Shike, M, Steinbach, G, Terdiman, JP, Weinberg, D & Winawer, SJ 2006, 'Colorectal cancer screening: Clinical Practice Guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 4, pp. 384-420. https://doi.org/10.6004/jnccn.2006.0033

@article{48cc0aee8dd348418e22a957aab304b8,

title = "Colorectal cancer screening: Clinical Practice Guidelines in oncology{\texttrademark}",

abstract = "Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema.",

keywords = "APC, Adenoma, Colorectal cancer, FAP, Fecal occult blood test, HNPCC, NCCN Clinical Practice Guidelines",

author = "Bernard Levin and Barthel, {James S.} and Burt, {Randall W.} and David, {Donald S.} and Ford, {James M.} and Giardiello, {Francis M.} and Gruber, {Stephen B.} and Halverson, {Amy L.} and Stanley Hamilton and Wendy Kohlmann and Ludwig, {Kirk A.} and Lynch, {Patrick M.} and Christopher Marino and Martin, {Edward W.} and Mayer, {Robert J.} and Boris Pasche and Pirruccello, {Samuel J.} and Ashwani Rajput and Rao, {M. Sambasiva} and Moshe Shike and Gideon Steinbach and Terdiman, {Jonathan P.} and David Weinberg and Winawer, {Sidney J.}",

year = "2006",

month = apr,

doi = "10.6004/jnccn.2006.0033",

language = "English (US)",

volume = "4",

pages = "384--420",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "4",

}

TY - JOUR

T1 - Colorectal cancer screening

T2 - Clinical Practice Guidelines in oncology™

AU - Levin, Bernard

AU - Barthel, James S.

AU - Burt, Randall W.

AU - David, Donald S.

AU - Ford, James M.

AU - Giardiello, Francis M.

AU - Gruber, Stephen B.

AU - Halverson, Amy L.

AU - Hamilton, Stanley

AU - Kohlmann, Wendy

AU - Ludwig, Kirk A.

AU - Lynch, Patrick M.

AU - Marino, Christopher

AU - Martin, Edward W.

AU - Mayer, Robert J.

AU - Pasche, Boris

AU - Pirruccello, Samuel J.

AU - Rajput, Ashwani

AU - Rao, M. Sambasiva

AU - Shike, Moshe

AU - Steinbach, Gideon

AU - Terdiman, Jonathan P.

AU - Weinberg, David

AU - Winawer, Sidney J.

PY - 2006/4

Y1 - 2006/4

N2 - Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema.

AB - Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema.

KW - APC

KW - Adenoma

KW - Colorectal cancer

KW - FAP

KW - Fecal occult blood test

KW - HNPCC

KW - NCCN Clinical Practice Guidelines

UR - http://www.scopus.com/inward/record.url?scp=33745932711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745932711&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2006.0033

DO - 10.6004/jnccn.2006.0033

M3 - Review article

C2 - 16569391

AN - SCOPUS:33745932711

SN - 1540-1405

VL - 4

SP - 384

EP - 420

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 4

ER -

Colorectal cancer screening: Clinical Practice Guidelines in oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this